Barr Fluoxetine Goal: 80% Generic Penetration In First Six Months
Executive Summary
Barr hopes to achieve 80% generic substitution for Lilly's Prozac within the first six months after launch of its generic 20 mg fluoxetine capsules.
You may also be interested in...
AstraZeneca Mulls AaiPharma Omeprazole Patent; Will Not List Two Others
AstraZeneca is expected to make a decision on whether to list an aaiPharma patent covering omeprazole in the "Orange Book" by the end of the month.
AstraZeneca Mulls AaiPharma Omeprazole Patent; Will Not List Two Others
AstraZeneca is expected to make a decision on whether to list an aaiPharma patent covering omeprazole in the "Orange Book" by the end of the month.
AaiPharma Fast-Acting Diclofenac NDA Filing Planned For 2002
AaiPharma plans to submit an NDA by the end of 2002 for its rapidly absorbed diclofenac, claiming a shorter time-to-peak benefit in acute pain.